Exagen inc. appoints chas mckhann to board of directors

Carlsbad, calif., july 17, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of innovative autoimmune testing solutions, announced today the appointment of chas mckhann to its board of directors, effective july 17, 2025.
XGN Ratings Summary
XGN Quant Ranking